"Precision Medicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile.
Descriptor ID |
D057285
|
MeSH Number(s) |
E02.574 H02.403.200.700
|
Concept/Terms |
Precision Medicine- Precision Medicine
- Medicine, Precision
- Personalized Medicine
- Medicine, Personalized
- Individualized Medicine
- Medicine, Individualized
|
Below are MeSH descriptors whose meaning is more general than "Precision Medicine".
Below are MeSH descriptors whose meaning is more specific than "Precision Medicine".
This graph shows the total number of publications written about "Precision Medicine" by people in this website by year, and whether "Precision Medicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 1 | 2 |
2010 | 8 | 0 | 8 |
2011 | 12 | 3 | 15 |
2012 | 5 | 4 | 9 |
2013 | 5 | 8 | 13 |
2014 | 5 | 5 | 10 |
2015 | 15 | 4 | 19 |
2016 | 11 | 9 | 20 |
2017 | 10 | 13 | 23 |
2018 | 14 | 8 | 22 |
2019 | 16 | 18 | 34 |
2020 | 18 | 12 | 30 |
2021 | 14 | 11 | 25 |
2022 | 3 | 11 | 14 |
2023 | 3 | 8 | 11 |
2024 | 8 | 8 | 16 |
2025 | 3 | 3 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Precision Medicine" by people in Profiles.
-
Care Team Attributes Predict Likelihood of Utilizing Pharmacogenomic Information During Inpatient Prescribing. Clin Transl Sci. 2025 Apr; 18(4):e70193.
-
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients. Oncotarget. 2025 Mar 12; 16:140-162.
-
Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials. J Natl Cancer Inst Monogr. 2025 Mar 01; 2025(68):22-29.
-
Digital twins as global learning health and disease models for preventive and personalized medicine. Genome Med. 2025 Feb 07; 17(1):11.
-
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine. Expert Rev Clin Immunol. 2025 Apr; 21(4):461-472.
-
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia. Am Heart J. 2025 Apr; 282:146-155.
-
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview. Biochim Biophys Acta Rev Cancer. 2025 Feb; 1880(1):189233.
-
ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine Era. Ann Surg Oncol. 2024 Dec; 31(13):8904-8905.
-
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):401-423.
-
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Nat Commun. 2024 Jul 11; 15(1):5837.